343 related articles for article (PubMed ID: 28585556)
1. Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis.
Kamal S; Khan MA; Seth A; Cholankeril G; Gupta D; Singh U; Kamal F; Howden CW; Stave C; Nair S; Satapathy SK; Ahmed A
Am J Gastroenterol; 2017 Oct; 112(10):1495-1505. PubMed ID: 28585556
[TBL] [Abstract][Full Text] [Related]
2. Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis.
Kim RG; Loomba R; Prokop LJ; Singh S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1521-1530.e8. PubMed ID: 28479502
[TBL] [Abstract][Full Text] [Related]
3. Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based study.
Chang FM; Wang YP; Lang HC; Tsai CF; Hou MC; Lee FY; Lu CL
Hepatology; 2017 Sep; 66(3):896-907. PubMed ID: 28318053
[TBL] [Abstract][Full Text] [Related]
4. Editorial: Statins and Liver Disease: Is it Time to Recommend Statins to Prevent Liver Disease Progression?
Price JC; Tien PC
Am J Gastroenterol; 2017 Oct; 112(10):1506-1507. PubMed ID: 28978973
[TBL] [Abstract][Full Text] [Related]
5. Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis.
Mohanty A; Tate JP; Garcia-Tsao G
Gastroenterology; 2016 Feb; 150(2):430-40.e1. PubMed ID: 26484707
[TBL] [Abstract][Full Text] [Related]
6. Statin use and virus-related cirrhosis: A systemic review and meta-analysis.
Ma X; Sun D; Li C; Ying J; Yan Y
Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):533-542. PubMed ID: 28866088
[TBL] [Abstract][Full Text] [Related]
7. Marijuana is not associated with progression of hepatic fibrosis in liver disease: a systematic review and meta-analysis.
Farooqui MT; Khan MA; Cholankeril G; Khan Z; Mohammed Abdul MK; Li AA; Shah N; Wu L; Haq K; Solanki S; Kim D; Ahmed A
Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):149-156. PubMed ID: 30234644
[TBL] [Abstract][Full Text] [Related]
8. Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: a propensity score weighted landmark analysis.
Wong JC; Chan HL; Tse YK; Yip TC; Wong VW; Wong GL
Aliment Pharmacol Ther; 2017 Nov; 46(10):1001-1010. PubMed ID: 28940673
[TBL] [Abstract][Full Text] [Related]
9. Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C.
Simon TG; King LY; Zheng H; Chung RT
J Hepatol; 2015 Jan; 62(1):18-23. PubMed ID: 25135867
[TBL] [Abstract][Full Text] [Related]
10. Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES.
Butt AA; Yan P; Bonilla H; Abou-Samra AB; Shaikh OS; Simon TG; Chung RT; Rogal SS;
Hepatology; 2015 Aug; 62(2):365-74. PubMed ID: 25847403
[TBL] [Abstract][Full Text] [Related]
11. Statin use and the risk of cirrhosis development in patients with hepatitis C virus infection.
Yang YH; Chen WC; Tsan YT; Chen MJ; Shih WT; Tsai YH; Chen PC
J Hepatol; 2015 Nov; 63(5):1111-7. PubMed ID: 26196278
[TBL] [Abstract][Full Text] [Related]
12. Statins Are Associated With a Decreased Risk of Severe Liver Disease in Individuals With Noncirrhotic Chronic Liver Disease.
Sharma R; Simon TG; Hagström H; Lochhead P; Roelstraete B; Söderling J; Verna EC; Emond J; Ludvigsson JF
Clin Gastroenterol Hepatol; 2024 Apr; 22(4):749-759.e19. PubMed ID: 37121528
[TBL] [Abstract][Full Text] [Related]
13. The effect of vitamin D supplementation on the progression of fibrosis in patients with chronic liver disease: A protocol for a systematic review and meta-analysis.
Chen T; Zuo X; Wang S; Yu P; Yuan J; Wei S; Chen J; Sun Y; Gao Y; Li X
Medicine (Baltimore); 2020 May; 99(19):e20296. PubMed ID: 32384521
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive evaluation of effects and safety of statin on the progression of liver cirrhosis: a systematic review and meta-analysis.
Gu Y; Yang X; Liang H; Li D
BMC Gastroenterol; 2019 Dec; 19(1):231. PubMed ID: 31888534
[TBL] [Abstract][Full Text] [Related]
15. Use of Statins in Patients with Chronic Liver Disease and Cirrhosis: Current Views and Prospects.
Vargas JI; Arrese M; Shah VH; Arab JP
Curr Gastroenterol Rep; 2017 Sep; 19(9):43. PubMed ID: 28752475
[TBL] [Abstract][Full Text] [Related]
16. Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study.
Huang YW; Lee CL; Yang SS; Fu SC; Chen YY; Wang TC; Hu JT; Chen DS
Am J Gastroenterol; 2016 Jul; 111(7):976-85. PubMed ID: 27166128
[TBL] [Abstract][Full Text] [Related]
17. SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation.
Kaplan DE; Mehta R; Garcia-Tsao G; Albrecht J; Aytaman A; Baffy G; Bajaj J; Hernaez R; Hunt K; Ioannou G; Johnson K; Kanwal F; Lee TH; Monto A; Pandya P; Schaubel D; Taddei TH
Contemp Clin Trials; 2021 May; 104():106367. PubMed ID: 33771685
[TBL] [Abstract][Full Text] [Related]
18. Statin use and prognosis of lung cancer: a systematic review and meta-analysis of observational studies and randomized controlled trials.
Xia DK; Hu ZG; Tian YF; Zeng FJ
Drug Des Devel Ther; 2019; 13():405-422. PubMed ID: 30774306
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES.
Simon TG; Bonilla H; Yan P; Chung RT; Butt AA
Hepatology; 2016 Jul; 64(1):47-57. PubMed ID: 26891205
[TBL] [Abstract][Full Text] [Related]
20. Statin therapy in chronic viral hepatitis: a systematic review and meta-analysis of nine studies with 195,602 participants.
Vahedian-Azimi A; Shojaie S; Banach M; Heidari F; Cicero AFG; Khoshfetrat M; Jamialahmadi T; Sahebkar A
Ann Med; 2021 Dec; 53(1):1227-1242. PubMed ID: 34296976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
